Illumina invests in 7 startups focused on breakthrough therapies, diagnostics
Georgejason/iStock Editorial via Getty Images                 

Illumina (NASDAQ:ILMN)
said itÂ has invested in seven new startups advancing breakthrough therapeutics, diagnostics, DNA storage, mental wellness, and sustainable foods applications.
TheÂ companies will join the fourth global funding cycle of Illumina Accelerator San Francisco Bay Area and Cambridge, U.K.
The seven companies to join are:Â 4SR Biosciences;Â B4X;Â Cache DNA;Â CRISP-HR Therapeutics;Â NonExomics;Â Purpose Health; andÂ Rethink Bio.
Illumina said the company creation engine is focused on partnering withÂ entrepreneurs to build breakthrough genomics startups.
TheÂ Illumina Accelerator portfolio has grown to 68 startups.